Mesoblast (ASX: MSB) – Mesoblast Hits Patient Recruitment Target in CLBP
Mesoblast Limited has achieved full patient recruitment for its Phase 3 pivotal trial evaluating rexlemestrocel-L as a treatment for chronic low...
Mesoblast Limited has achieved full patient recruitment for its Phase 3 pivotal trial evaluating rexlemestrocel-L as a treatment for chronic low...
Nickel Industries posted its strongest operational earnings since December 2023 during the March 2026 quarter, with adjusted EBITDA from operations...
Codan Limited has delivered a significant upgrade to its earnings guidance, now expecting EBIT of approximately $235 million and NPAT of...
Ramelius Resources has updated its FY26 all-in sustaining costs (AISC) guidance to A$1,900-2,050 per ounce, up from the previous A$1,700-1,900 per...
Zimplats' March quarter report reveals a significant albeit temporary disruption to operations due to scheduled smelter maintenance conducted in...
Westgold Resources delivered a compelling earnings report for the March 2026 quarter, generating an underlying cash build of $285 million that...
St Barbara Limited has secured the financial backing and strategic partnership to accelerate its transformation into a major gold producer, with...
oOh!media Limited has received an unsolicited, non-binding indicative offer from Pacific Equity Partners to acquire the company for A$1.40 per share...
Insignia Financial Limited's acquisition by Daintree BidCo Pty Ltd has now been implemented, effective 28 April 2026. Daintree BidCo, established by...
Nickel Industries has executed a new US$450 million syndicated loan facility led by PT Bank Negara Indonesia, replacing maturing debt and extending...
MF & Co. Asset Management is a boutique investment firm offering Equity Capital Markets and derivative general advice & trade execution services.
We are specialists in advising and trading in Australian and US Equities, Index & Equity Options and Options on Futures.
Australia
1300 889 603
International
+61 2 8378 7199
M-F: 8am-5pm
Suite 803, Level 8
70 Pitt St, Sydney, NSW 2000